Effects of Motivational Interviewing for Long-term Sick Absence

NCT03212118 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 774

Last updated 2022-09-23

No results posted yet for this study

Summary

Long-term sickness absence has considerable impact on social functioning, families involved, the employer, and society as a whole. Preventing long-term sickness absence and increase the likelihood of return to work (RTW) are critical concerns for industrialized countries across the world. Motivational factors contributing to RTW and maintenance of work participation are therefore of importance to explore in order to get the person back to work after long-term sick leave. Motivational interviewing (MI) is an empirically validated psychological approach that may be particularly useful in a RTW context. Even though MI has been widely studied and is considered a flexible intervention strategy in different domains, its effectiveness in improving RTW has not yet been studied.

The aim of this study is to evaluate whether MI provided by trained caseworkers at The Norwegian Labour and Welfare Administration (NAV) to sick-listed users with unselected diagnoses facilitates RTW compared with follow-up as usual.

Conditions

  • Sick Leave

Interventions

BEHAVIORAL

Treatment as usual (TAU-0)

The standard NAV procedure, which consists of a telephone call within 8 weeks to an employer who have employees on 100% sick leave, in addition to regular NAV conversations "on-demand" (not "fixed intervals") between the NAV caseworkers and the employees.

BEHAVIORAL

Structured talks (TAU-2)

Two structured talks (not including elements from motivational interviewing)

BEHAVIORAL

motivational interviewing (MI)

Two structured talks (must have a valid motivational interviewing content).

Sponsors & Collaborators

  • University of Bergen

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • National Center for Occupational Rehabilitation, Rauland

    collaborator UNKNOWN
  • Deakin University

    collaborator OTHER
  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Egil Andreas Fors, phd prof · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-10-22
Completion
2022-07-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03212118 on ClinicalTrials.gov